BELLICUM PHARMACEUTICALS
Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic infectious diseases. Bellicum's novel approach is to utilize precise knowledge of the signaling pathways that regulate the immune response to target specific factors that can influence the potency and duration of this response.
BELLICUM PHARMACEUTICALS
Industry:
Biotechnology Health Care Health Diagnostics Oncology Therapeutics
Founded:
2004-07-01
Address:
Houston, Texas, United States
Country:
United States
Website Url:
http://www.bellicum.com
Total Employee:
11+
Status:
Active
Contact:
(832) 384-1100
Email Addresses:
[email protected]
Total Funding:
324.58 M USD
Technology used in webpage:
Domain Not Resolving IPv6 Pound Sterling Common Name Invalid Microsoft Japanese Yen COVID-19 Sectigo SSL Sectigo Domain SSL Unified Layer
Similar Organizations
Acrivon Therapeutics
Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.
Aer Therapeutics
Aer Therapeutics, a clinical-stage biopharmaceutical company developing therapeutic solutions for muco-obstructive lung diseases.
Avstera Therapeutics
Avstera Therapeutics is an oncology-focused biotech company that fulfil unmet needs of cancer patients.
CG Oncology
CG Oncology is a clinical-stage biopharmaceutical company focused on the development of oncolytic immunotherapies to combat cancer.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Geneos Therapeutics
Geneos Therapeutics is a developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment.
ORIC Pharmaceuticals
ORIC Pharmaceuticals operates as a biopharmaceutical company.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
Tmunity Therapeutics
Tmunity Therapeutics is developing novel products to unleash the immunological potential of T cells
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Cancer Prevention and Research Institute of Texas
Cancer Prevention and Research Institute of Texas investment in Grant - Bellicum Pharmaceuticals
Hercules Capital
Hercules Capital investment in Post-IPO Debt - Bellicum Pharmaceuticals
RA Capital Management
RA Capital Management investment in Series C - Bellicum Pharmaceuticals
Ridgeback Capital
Ridgeback Capital investment in Series C - Bellicum Pharmaceuticals
Ridgeway Capital Partners
Ridgeway Capital Partners investment in Series C - Bellicum Pharmaceuticals
Sabby Capital
Sabby Capital investment in Series C - Bellicum Pharmaceuticals
Aju IB Investment
Aju IB Investment investment in Series C - Bellicum Pharmaceuticals
Jennison Associates
Jennison Associates investment in Series C - Bellicum Pharmaceuticals
Redmile Group
Redmile Group investment in Series C - Bellicum Pharmaceuticals
Perceptive Advisors
Perceptive Advisors investment in Series C - Bellicum Pharmaceuticals
Official Site Inspections
http://www.bellicum.com Semrush global rank: 3.9 M Semrush visits lastest month: 2.91 K
- Host name: 192-185-225-144.unifiedlayer.com
- IP address: 192.185.225.144
- Location: Houston United States
- Latitude: 29.8284
- Longitude: -95.4696
- Metro Code: 618
- Timezone: America/Chicago
- Postal: 77092
More informations about "Bellicum Pharmaceuticals"
Bellicum Pharmaceuticals - Crunchbase Company Profile & Funding
Bellicum Pharmaceuticals is a clinical stage company developing next generation therapeutic vaccines and other immunotherapeutic approaches for the treatment of cancer and chronic …See details»
Bellicum Company Profile | Management and Employees List
Bellicum Profile and History Bellicum Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the …See details»
SEC.gov
ORGANIZATION, BASIS OF PRESENTATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES. Organization. Bellicum Pharmaceuticals, Inc. (“Bellicum”) is a …See details»
Bellicum Pharmaceuticals Inc - The Globe and Mail
May 24, 2003 See the company profile for Bellicum Pharmaceuticals Inc (BLCM) including business summary, industry/sector information, business summary, corporate governance, …See details»
Bellicum Pharmaceuticals - Contacts, Employees, Board Members, …
Organization. Bellicum Pharmaceuticals . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News ... Bellicum Pharmaceuticals has 11 current employee profiles, …See details»
Bellicum Pharmaceuticals - Funding, Financials, Valuation & Investors
Bellicum Pharmaceuticals is registered under the ticker NASDAQ:BLCM . Bellicum Pharmaceuticals is funded by 15 investors. Cancer Prevention and Research Institute of …See details»
Bellicum - Ownership and Business Overview - Mergr
Bellicum is a clinical-stage biopharmaceutical company focused on discovering and developing novel cellular immunotherapies for various forms of cancer, including hematological cancers …See details»
Bellicum Pharmaceuticals - VentureRadar
Bellicum is dedicated to developing safer and more effective cell therapies to treat cancers and other serious, life-threatening diseases. The Company's cell therapies are engineered with a …See details»
Bellicum Pharmaceuticals, Inc - Devex
Learn more about Bellicum Pharmaceuticals, Inc's jobs, projects, latest news, contact information and geographical presence. Bellicum is engineering high-performance cellular …See details»
Search - Bellicum
The Investor Relations website contains information about Bellicum's business for stockholders, potential investors, and financial analysts.See details»
Bellicum Pharmaceuticals Announces Management Changes
May 15, 2017 Bellicum assumes no obligation to update our forward-looking statements whether as a result of new information, future events or otherwise, after the date of this press release. …See details»
Bellicum Pharmaceuticals, Inc. | LinkedIn
Bellicum Pharmaceuticals, Inc. | 9,464 followers on LinkedIn. Bellicum is a clinical-stage biopharmaceutical company that is driving the future of celluar IO. | Bellicum Pharmaceuticals, …See details»
Bellicum Pharmaceuticals - Updates, News, Events, Signals
Bellicum Pharmaceuticals is a clinical-stage biopharmaceutical company that is driving the future of cellular immuno-oncology (IO). Search Crunchbase. Start Free Trial . Chrome Extension. …See details»
Bellicum Pharmaceuticals Provides Operational Update and …
Dec 31, 2018 HOUSTON, March 12, 2019 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for …See details»
Bellicum Pharmaceuticals, Inc. | Insights
Jan 15, 2024 Latest on Bellicum Pharmaceuticals, Inc. Already A Biomedtracker Subscriber? You have access to the full company record through your subscription. Go To Biomedtracker.See details»
Bellicum Pharmaceuticals, Inc. (BLCM): VRIO Analysis [10-2024 …
Bellicum Pharmaceuticals, Inc. (BLCM) showcases a robust portfolio through its VRIO analysis, revealing a blend of value, rarity, inimitability, and organization across various assets. From a …See details»
Bellicum Announces Interim BPX-601 Data and Corporate …
After an extensive review of its organization and programs, the company has implemented a restructuring plan, including a reduction in staff, to focus its efforts on its clinical GoCAR-T ® …See details»
The Bellicum
Empowering the next generationSee details»
Bellicum Pharmaceuticals to Participate in the H.C. Wainwright …
Sep 1, 2022 Bellicum’s GoCAR-T® product candidates, BPX-601 and BPX-603, are designed to be more efficacious CAR-T cell products capable of overriding key immune inhibitory …See details»